About this job

A leading global biopharmaceutical organisation is seeking a Senior Evidence Synthesis Lead to take ownership of global payer evidence and access strategy across key assets and indications. This is a senior, high-impact role operating across the full product life cycle, from peri-launch through in-market optimisation.

Key Responsibilities:

• Lead the development and delivery of global payer evidence deliverables, including Global Value Dossiers and assessment reports, ensuring quality, governance compliance, and timely execution.
• Own payer evidence strategy from peri-launch through critical life-cycle milestones.
• Lead early Health Technology Assessment (HTA) engagement activities and preparation.
• Translate global access strategy into clear, locally adaptable value narratives and tools.
• Support regional and local teams with launch readiness, HTA submissions, payer negotiations, and objection handling.
• Conduct readiness reviews of country-level payer value narratives and access materials.
• Identify evidence gaps and coordinate with clinical development, HEOR, RWE, pricing, medical, and commercial teams to address them.
• Ensure payer evidence generation aligns with pricing, reimbursement, and lifecycle strategy.
• Engage external experts, advisors, and vendors to validate payer evidence and access strategies.
• Contribute to scientific publications, conference abstracts, and payer-relevant communications.
• Present value narratives to external stakeholders where appropriate.
• Represent payer and access perspectives within global asset teams and governance forums.
• Lead cross-functional projects and support the development of team members in a matrix environment.
• Enable best-practice sharing across regions to strengthen access outcomes.

Requirements:

Essential:

• Approximately 10 years’ experience within the (bio)pharmaceutical industry.
• 2–6 years’ experience in market access, payer evidence, HEOR, or HTA-focused roles.
• Demonstrated experience supporting product launches and life cycle access strategy.
• Proven ability to lead projects or teams in a global, matrixed environment.
• Bachelor’s degree in a scientific, health-related, or business discipline.
• Strong written and verbal communication skills, with the ability to translate complex evidence into clear value messages.

Desirable

• Experience in a global oversight role for access strategy or payer evidence development.
• Hands-on experience with HTA submissions and payer interactions.
• Development of global value tools for local adaptation.
• Experience working with external stakeholders, advisors, or KOLs.
• Master’s degree, MBA, or PhD in life sciences, health economics, epidemiology, health policy, or a related field.

Keywords: HTA, Payer evidence, HEOR, Pharmaceutical, VRS9357DT.